Brodrick, Caroline Frances
Description
Dementia is an increasing health concern for Australia with rates
of diagnoses of dementia predicted to rise within our ageing
population (Prince, Albanese, Guerchet, & Prina, 2014). The
potential effects are widespread not only at the individual level
but at a socioeconomic level with associated medical costs
(Cerejeira, Lagarto, & Mukaetova-Ladinska, 2012; Wimo, Jonsson,
Bond, Prince, & Winblad, 2013). Overall, this highlights the
importance...[Show more] for medical professionals and researchers alike to
focus on methods of risk reduction. One method of risk reduction
will be to investigate predictors of preclinical dementia
syndromes, with the aim of implementing earlier intervention to
prevent or delay progression to cognitive disorders.
Past research indicates that depression is predictive for the
onset of dementia and cognitive impairment/decline (Diniz,
Butters, Albert, Dew, & Reynolds, 2013; Gao et al 2013). However
a minimal amount of research has investigated whether specific
depressive symptoms and positive or negative affect are
predictive of preclinical dementia syndromes. Overall, this gap
in the literature suggests that further research is needed within
this area.
The current research was conducted in conjunction with the
Personality and Total Health (PATH) Through Life Study which is a
population based prospective longitudinal study. Study 1 and
Study 2 consisted of a total of 2551 participants in the 60+
cohort study. The Brief Patient Health Questionnaire (BPHQ),
Goldberg Anxiety Depression Scale (GADS) and Positive and
Negative Affect Scale (PANAS) were administered to measure
baseline symptoms of depression and positive and negative affect.
A two-staged sampling design was implemented to diagnose Mild
Cognitive Impairment (MCI) and Any- Mild Cognitive Disorders
(Any-MCD).
Study 1 (Chapter 3) examined whether baseline depressive symptoms
predicted progression to MCI or Any-MCD from wave 1 to 2 and wave
2 to 3. The results suggest that depressive symptoms of lacking
energy/tired, loss of interest/pleasure, loss of confidence,
difficulties concentrating, feeling down, depressed or hopeless
and feeling bad about oneself were significant predictors of MCI
from wave 1 to 2. Depressive symptoms of lacking energy/tired,
loss of interest/pleasure, loss of confidence, difficulties
concentrating, feeling down, depressed or hopeless and feeling
bad about oneself, psychomotor slowing, felt worse in the morning
and poor appetite or overeating were significant predictors of
progression to Any-MCD from wave 1 to 2. Specific symptoms
including lacking energy/feeling tired, lost interest/pleasure in
doing things and difficulties concentrating were stronger
predictors of progression to cognitive disorders from wave 1 to
2. These symptoms remained significant when adjusting for
demographics of gender and education and covariates (employment,
physical activity, anxiety and depression medication, partner
status smoking, high blood pressure, diabetes, stroke and heart
disease); and were cross validated between two depressive
measures. The results suggest that specific symptoms are more
predictive of progression to cognitive disorders at distinct time
points. The findings for depressive symptoms as predictors of
progression to cognitive impairment from wave 2 to 3 were
intriguing, indicating that endorsing “yes” to GADS items
“lacking energy” and “felt slowed up” significantly
decreased the odds of progressing to Any-MCD. While GADS items
“lost interest,” “lost confidence,” “felt hopeless”
and “lost weight” were excluded from the current analyses due
to participants in the healthy/cognitive groups not endorsing
“yes” to these symptoms at baseline. The BPHQ items were
excluded from analyses from wave 2 to 3 due to participants not
endorsing “yes” to these symptoms at baseline. Covariates
including gender and partner status were significant predictors
of progression to cognitive impairment.
Study 2 (Chapter 4) examined whether baseline measures of
positive and negative affect predicted progression to MCI or
Any-MCD from wave 1 to 2 and wave 2 to 3. Positive and negative
affect were not significant predictors of MCI or Any-MCD from
wave 1 to 2 or wave 2 to 3. Demographics including gender and
education were significant predictors of progression to cognitive
impairment.
Overall, the results suggest that specific depressive symptoms
are predictive of progression to cognitive disorders. Our
findings suggest that additional research is needed within the
field to increase our understanding of the role of depressive
symptomology and affect in predicting cognitive impairment. The
current findings are preliminary however with further research
this area could have important clinical implications particularly
that depressive symptoms may need to be monitored in individuals
aged 60 years and above with the intent of earlier detection, and
prevention/delay of the onset of cognitive disorders.
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.